{{Rsnum
|rsid=710218
|Gene=ME2
|Chromosome=1
|position=42961547
|Orientation=minus
|GMAF=0.3834
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=SLC2A1-AS1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 56.6 | 37.2 | 6.2
| HCB | 47.4 | 40.9 | 11.7
| JPT | 46.9 | 46.0 | 7.1
| YRI | 2.7 | 41.5 | 55.8
| ASW | 22.8 | 33.3 | 43.9
| CHB | 47.4 | 40.9 | 11.7
| CHD | 42.2 | 50.5 | 7.3
| GIH | 54.5 | 37.6 | 7.9
| LWK | 4.5 | 34.5 | 60.9
| MEX | 39.7 | 46.6 | 13.8
| MKK | 9.0 | 35.9 | 55.1
| TSI | 56.9 | 42.2 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22707195
|Title=Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis
}}

{{PMID|20540786|OA=1
}} The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.

{{PMID|21332301}} Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma.

{{PMID Auto
|PMID=23427181
|Title=Family-Based Association Study Between SLC2A1, HK1, and LEPR Polymorphisms With Myelomeningocele in Chile
}}

{{PMID Auto
|PMID=23631762
|Title=Genotyping analysis and 18FDG uptake in breast cancer patients: a preliminary research
|OA=1
}}

{{on chip | Affy GenomeWide 6}}